FIELD: molecular biology, biochemistry. SUBSTANCE: invention relates to synthetic single-stranded RNA molecules showing highly specific endonuclease activity. Ribosime has hybridizing and catalytic regions. Hybridizing region has one or more branches of a single-stranded RNA. The preferable ribosime has a catalytic region including the sequence AAGC*GAGXAGUC in "hairpin" N1* N2 structure where * means bases pairing between complementary nucleotides, X means any ribonucleotide and N1 and N2 mean ribonucleotides with complementary sequences, at least, in part of their length. Ribosime splits RNA-target after triplet xUy where x is any ribonucleotide, U means uracil and y is adenine, cytosine or uracil. The nucleotide sequence encoding the required ribosime is obtained followed by its ligation with a suitable transfer vector containing DNA or RNA or their combination. The ligated sequence is transcribed using RNA-polymerase. RNA-target into the cells is subjected by ribosime effect that is able to carry out the specific cleavage of indicated RNA-target in the site taken so manner that the indicated RNA-target is hybridized into the cell with ribosime to induce inactivation of RNA-target. Invention ensures to obtain ribosimes that are able to hybridize effectively with the broad raw of target RNA-sequences but without modifying the cleavage RNA-targent. EFFECT: improved method of ribosime preparing. 11 cl, 38 dwg, 9 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT DNA AS AGENT FOR INHIBITION OF RNA FUNCTION IN LIVING ORGANISM | 1990 |
|
RU2136751C1 |
METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY | 1998 |
|
RU2214280C2 |
SUBSTRATES OF NUCLEIC ACIDS WITH ENZYMATIC ACTIVITY | 2012 |
|
RU2650806C2 |
TREATMENT OF FIBROBLAST GROWTH FACTOR 21 (FGF21) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FGF21 | 2011 |
|
RU2610661C2 |
TREATMENT OF ALPHA-L-IDURONIDASE (IDUA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IDUA | 2011 |
|
RU2597972C2 |
TREATMENT OF DISEASES CONNECTED WITH SITE-1 MEMBRANE-IMPACTED PEPTIDASE OF TRANSCRIPTION FACTORS (MBTPS1), BY INHIBITING NATURAL ANTISENSE TRANSCRIPT TO MBTPS1 | 2010 |
|
RU2639550C2 |
CRISPR-CAS SYSTEM COMPONENTS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2701662C2 |
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES | 1999 |
|
RU2270864C2 |
TREATMENT OF DISEASES ASSOCIATED WITH SUBSTRATE OF INSULIN RECEPTOR 2 (IRS2) BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 | 2010 |
|
RU2616283C2 |
GENETIC MAKE-UPS FOR ANTI-HIV THERAPY | 2010 |
|
RU2426788C1 |
Authors
Dates
2000-01-10—Published
1988-12-14—Filed